Published in Nephrol Dial Transplant on December 27, 2009
Patient- and provider-reported information about transplantation and subsequent waitlisting. J Am Soc Nephrol (2014) 1.06
Epidemiology and management of end-stage renal disease in the elderly. Nat Rev Nephrol (2011) 1.02
Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant (2015) 0.90
A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int (2015) 0.89
The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single Chinese center. Medicine (Baltimore) (2014) 0.84
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study. Transplant Res (2013) 0.82
Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging Dis (2012) 0.81
Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrol (2016) 0.80
Facilitating access to the renal transplant waiting list does not increase the number of transplantations: comparative study of two French regions. Clin Kidney J (2016) 0.75
Should patients older than 65 years be offered a second kidney transplant? BMC Nephrol (2017) 0.75
Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts. PLoS One (2016) 0.75
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation? Transplantation (2016) 0.75
Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors. J Am Soc Nephrol (2016) 0.75
Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient. Drugs Aging (2017) 0.75
[Kidney transplantation in old age]. Z Gerontol Geriatr (2016) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69
An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy (2007) 2.26
Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant (2007) 1.72
Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int (2008) 1.56
How old is old for transplantation? Am J Transplant (2004) 1.42
The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol (2003) 1.42
Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.37
Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis (2005) 1.32
How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant (2004) 1.31
A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation (2000) 1.30
Challenges in the counseling and management of older kidney transplant candidates. Am J Kidney Dis (2006) 1.15
Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol (2001) 1.15
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Trends in organ donation and transplantation in the United States, 1997-2006. Am J Transplant (2008) 1.10
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation (2009) 1.09
Health-related quality of life (HRQOL) in end stage renal disease (ESRD) patients over 65 years. Geriatr Nephrol Urol (1998) 1.08
Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant (2003) 1.08
Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant (2000) 1.02
Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States. Int Urol Nephrol (2005) 1.00
A decade of progress in kidney transplantation. Transplantation (2004) 0.90
Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly. Nephrol Dial Transplant (2009) 0.89
Potent early immune response after kidney transplantation in patients of the European senior transplant program. Transplantation (2009) 0.89
Kidneys from deceased donors more than 75 years perform acceptably after transplantation. Transplantation (2009) 0.88
Kidney transplantation in the elderly--the Norwegian experience. Nephrol Dial Transplant (2007) 0.88
Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients. J Am Soc Nephrol (2008) 0.85
Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation (2009) 0.84
Renal transplant from very old donors: how far can we go? Transplantation (2009) 0.82
Is renal transplantation the most cost-effective and preferable therapy for patients suffering from end-stage renal disease or not? Health Policy (2008) 0.80
An old virtue to improve senior programs. Transpl Int (2008) 0.79
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
Preeclampsia and the risk of end-stage renal disease. N Engl J Med (2008) 3.31
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant (2007) 2.91
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int (2008) 2.36
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ (2006) 2.29
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13
Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg (2013) 2.07
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation (2015) 2.00
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes (2005) 1.96
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol (2006) 1.90
CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation (2009) 1.79
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation (2004) 1.64
Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl (2002) 1.58
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int (2004) 1.57
Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol (2007) 1.57
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol (2013) 1.47
Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr (2009) 1.46
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant (2004) 1.46
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol Dial Transplant (2014) 1.45
Clinical experience with microdialysis catheters in pediatric liver transplants. Liver Transpl (2013) 1.45
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant (2007) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases: The RAPID Concept. Ann Surg (2015) 1.40
An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant (2009) 1.39
Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study. Transplantation (2011) 1.38
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol (2014) 1.38
Diagnosing PTDM. Transplantation (2002) 1.37
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant (2002) 1.36
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation (2008) 1.34
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24
Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant (2011) 1.23
The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. Nephrol Dial Transplant (2010) 1.23
Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant (2006) 1.19
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients-A Prospective, Randomized Study. Transplantation (2015) 1.19
Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol (2002) 1.19
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol (2004) 1.13
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation (2011) 1.13
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study. Transpl Int (2010) 1.10
Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients. Eur Radiol (2012) 1.09
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation (2009) 1.09
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant (2011) 1.08
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry. Transplantation (2009) 1.08
Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transplant (2010) 1.07
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. Pharmacogenet Genomics (2008) 1.07
Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance? Transplantation (2014) 1.07
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol (2011) 1.04
The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Nephrol Dial Transplant (2009) 1.04
Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant (2008) 1.03
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study. BMC Endocr Disord (2010) 1.01
Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int (2008) 1.01
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol (2010) 1.01
Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients. J Med Virol (2006) 1.01
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant (2003) 1.01
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Nephrol Dial Transplant (2005) 1.00
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation (2011) 1.00
No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation. Transplantation (2007) 0.98
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics (2012) 0.98
Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey. Health Qual Life Outcomes (2012) 0.98
Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation (2007) 0.98
Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant (2002) 0.97
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int (2005) 0.97
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis (2010) 0.97
Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie). Am J Kidney Dis (2011) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol (2011) 0.95
Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions? Br J Health Psychol (2012) 0.95
Use of Neoral C monitoring: a European consensus. Transpl Int (2005) 0.94
The risk of living kidney donation. Nephrol Dial Transplant (2003) 0.94
Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib Nephrol (2009) 0.93
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation (2003) 0.93
Patients' representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant (2009) 0.93
Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant (2007) 0.93
Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr (2009) 0.93
Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis (2006) 0.92
Improvement of post-transplant lymphocele treatment in the laparoscopic era. Transpl Int (2002) 0.92